SCHEMBL27637307

SCHEMBL27637307

Cc1c[nH]c2c(C)cc(O)cc12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 4/20 0.39
▸ CHRM1 P11229 1/20 0.39
▸ ALOX15 P16050 1/20 0.39
▸ MAOA P21397 1/20 0.39
▸ TBXA2R P21731 1/20 0.39
▸ ADRA1A P35348 1/20 0.39
▸ HTR2B P41595 1/20 0.39
▸ RXFP4 Q8TDU9 1/20 0.34
▸ RXFP3 Q9NSD7 1/20 0.34
▸ ATM Q13315 2/20 0.34
▸ BRPF1 P55201 1/20 0.34
▸ CYP1A2 P05177 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ ACHE P22303 2/20 0.33
▸ ALDH1A1 P00352 2/20 0.33
▸ MEN1 O00255 1/20 0.32
▸ HSP90AA1 P07900 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ NR4A2 P43354 1/20 0.32
▸ CLK2 P49760 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20674516 0.77 AR (0.39) CYP3A4BRPF1CYP1A2CYP2C19ACHE
SCHEMBL20688241 0.77 MAPT (0.50) CYP3A4ATMBRPF1CYP1A2CYP2C19
SCHEMBL20674101 0.76 IKBKB (0.39) ATMBRPF1ALDH1A1
SCHEMBL21958611 0.75 GLO1 (0.34) ALDH1A1
SCHEMBL1144808 0.74 GSK3B (0.36) CYP3A4ATMBRPF1CYP1A2CYP2C19
SCHEMBL30858656 0.74 AR (0.48) CYP3A4ATMBRPF1CYP1A2CYP2C19
SCHEMBL29226865 0.74 LMNA (0.41) CYP3A4BRPF1ACHEALDH1A1MEN1
SCHEMBL30234188 0.74 LMNA (0.41) CYP3A4BRPF1ACHEALDH1A1MEN1
SCHEMBL20674478 0.73 LMNA (0.38) ALDH1A1KMT2ALMNAPOLB
SCHEMBL1144695 0.72 NOTUM (0.47) CYP3A4ALOX15BRPF1CYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1863794-A Quinazoline derivatives as angiogenesis inhibitors ASTRAZENECA AB (SE) 2006-11-15 — — CN disclosed
Send feedback